MetabolomicsPub Date : 2024-07-27DOI: 10.1007/s11306-024-02116-z
Natalia Palacios, Shilpa N. Bhupathiraju, Rachel S. Kelly, Jong Soo Lee, Jose M. Ordovas, Katherine L. Tucker
{"title":"Acylcarnitines are associated with lower depressive symptomatology in a mainland puerto rican cohort","authors":"Natalia Palacios, Shilpa N. Bhupathiraju, Rachel S. Kelly, Jong Soo Lee, Jose M. Ordovas, Katherine L. Tucker","doi":"10.1007/s11306-024-02116-z","DOIUrl":"https://doi.org/10.1007/s11306-024-02116-z","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Introduction</h3><p>Recent studies have implicated acetyl-<span>l</span>-carnitine as well as other acylcarnitines in depression. To our knowledge, no untargeted metabolomics studies have been conducted among US mainland Puerto Ricans.</p><h3 data-test=\"abstract-sub-heading\">Objectives</h3><p>We conducted untargeted metabolomic profiling on plasma from 736 participants of the Boston Puerto Rican Health Study.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Using Weighted Gene Co-expression Network Analysis, we identified metabolite modules associated with depressive symptomatology, assessed via the Center for Epidemiologic Studies Depression scale. We identified metabolites contributing to these modules and assessed the relationship between these metabolites and depressive symptomatology.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>621 annotated metabolites clustered into eight metabolite modules, of which one, the acylcarnitine module, was significantly inversely associated with depressive symptomatology (<i>β</i> = − 27.7 (95% CI (− 54.5—0.8); p = 0.043). Several metabolite hub features in the acylcarnitine module were significantly associated with depressive symptomatology, after correction for multiple comparisons.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>In this untargeted plasma metabolomics study among mainland Puerto Rican older adults, acylcarnitines, as a metabolite module were inversely associated with depressive symptomatology.</p>","PeriodicalId":18506,"journal":{"name":"Metabolomics","volume":"31 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141770497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MetabolomicsPub Date : 2024-07-27DOI: 10.1007/s11306-024-02144-9
Kursat Gundogan, Mary M. Nellis, Nurhayat T. Ozer, Serap S. Ergul, Gulsah G. Sahin, Sahin Temel, Recep C. Yuksel, Sami Teeny, Jessica A. Alvarez, Murat Sungur, Dean P. Jones, Thomas R. Ziegler
{"title":"High-resolution plasma metabolomics and thiamine status in critically Ill adult patients","authors":"Kursat Gundogan, Mary M. Nellis, Nurhayat T. Ozer, Serap S. Ergul, Gulsah G. Sahin, Sahin Temel, Recep C. Yuksel, Sami Teeny, Jessica A. Alvarez, Murat Sungur, Dean P. Jones, Thomas R. Ziegler","doi":"10.1007/s11306-024-02144-9","DOIUrl":"https://doi.org/10.1007/s11306-024-02144-9","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Introduction</h3><p>Thiamine (Vitamin B1) is an essential micronutrient and is classically considered a co-factor in energy metabolism. The association between thiamine status and whole-body metabolism in critical illness has not been studied.</p><h3 data-test=\"abstract-sub-heading\">Objectives</h3><p>To determine association between whole blood thiamine pyrophosphate (TPP) concentrations and plasma metabolites and connected metabolic pathways using high resolution metabolomics (HRM) in critically ill patients.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Cross-sectional study performed at Erciyes University Hospital, Kayseri, Turkey and Emory University, Atlanta, GA, USA. Participants were critically ill adults with an expected length of intensive care unit stay longer than 48 h and receiving chronic furosemide therapy. A total of 76 participants were included. Mean age was 69 years (range 33–92 years); 65% were female. Blood for TPP and metabolomics was obtained on the day of ICU admission. Whole blood TPP was measured by HPLC and plasma HRM was performed using liquid chromatography/mass spectrometry. Data was analyzed using regression analysis of TPP levels against all plasma metabolomic features in metabolome-wide association studies (MWAS). MWAS using the highest and lowest TPP concentration tertiles was performed as a secondary analysis.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Specific metabolic pathways associated with whole blood TPP levels in regression and tertile analysis included pentose phosphate, fructose and mannose, branched chain amino acid, arginine and proline, linoleate, and butanoate pathways.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Plasma HRM revealed that thiamine status, determined by whole blood TPP concentrations, was significantly associated with metabolites and metabolic pathways related to metabolism of energy, carbohydrates, amino acids, lipids, and the gut microbiome in adult critically ill patients.</p>","PeriodicalId":18506,"journal":{"name":"Metabolomics","volume":"13 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141770498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A study of 9 common breath VOCs in 504 healthy subjects using PTR-TOF-MS.","authors":"Zhunan Jia, Wei Qiang Ong, Fuchang Zhang, Fang Du, Velmurugan Thavasi, Venkatesan Thirumalai","doi":"10.1007/s11306-024-02139-6","DOIUrl":"10.1007/s11306-024-02139-6","url":null,"abstract":"<p><strong>Introduction: </strong>This study employs Proton-Transfer-Reaction Mass Spectrometry (PTR-MS) to analyze exhaled breath profiles of 504 healthy adults, focusing on nine common volatile organic compounds (VOCs): acetone, acetaldehyde, acetonitrile, ethanol, isoprene, methanol, propanol, phenol, and toluene. PTR-MS offers real-time VOC measurement, crucial for understanding breath biomarkers and their applications in health assessment.</p><p><strong>Objectives: </strong>The study aims to investigate how demographic factors-gender, age, and smoking history-affect VOC concentrations in exhaled breath. The objective is to enhance our understanding of breath biomarkers and their potential for health monitoring and clinical diagnosis.</p><p><strong>Methods: </strong>Exhaled breath samples were collected using PTR-MS, measuring concentrations of nine VOCs. The data were analyzed to discern distribution patterns across demographic groups.</p><p><strong>Results: </strong>Males showed higher average VOC levels for certain compounds. Propanol and methanol concentrations significantly increased with age. Smoking history influenced VOC levels, with differences among non-smokers, current smokers, and ex-smokers.</p><p><strong>Conclusion: </strong>This research provides valuable insights into demographic influences on exhaled VOC profiles, emphasizing the potential of breath analysis for health assessment. PTR-MS's real-time measurement capabilities are crucial for capturing dynamic VOC changes, offering advantages over conventional methods. These findings lay a foundation for advancements in non-invasive disease detection, highlighting the importance of considering demographics in breath biomarker research.</p>","PeriodicalId":18506,"journal":{"name":"Metabolomics","volume":"20 4","pages":"79"},"PeriodicalIF":3.5,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MetabolomicsPub Date : 2024-07-16DOI: 10.1007/s11306-024-02146-7
Francesca Day, Justin O'Sullivan, Farha Ramzan, Chris Pook
{"title":"Polar metabolomics using trichloroacetic acid extraction and porous graphitic carbon stationary phase.","authors":"Francesca Day, Justin O'Sullivan, Farha Ramzan, Chris Pook","doi":"10.1007/s11306-024-02146-7","DOIUrl":"10.1007/s11306-024-02146-7","url":null,"abstract":"<p><strong>Introduction: </strong>Accurately identifying and quantifying polar metabolites using untargeted metabolomics has proven challenging in comparison to mid to non-polar metabolites. Hydrophilic interaction chromatography and gas chromatography-mass spectrometry are predominantly used to target polar metabolites.</p><p><strong>Objectives: </strong>This study aims to demonstrate a simple one-step extraction combined with liquid chromatography-mass spectrometry (LC-MS) that reliably retains polar metabolites.</p><p><strong>Methods: </strong>The method involves a MilliQ + 10% trichloroacetic acid extraction from 6 healthy individuals serum, combined with porous graphitic carbon liquid chromatography-mass spectrometry (LC-MS). The coefficient of variation (CV) assessed retention reliability of polar metabolites with logP as low as - 9. QreSS (Quantification, Retention, and System Suitability) internal standards determined the method's consistency and recovery efficiency.</p><p><strong>Results: </strong>The method demonstrated reliable retention (CV < 0.30) of polar metabolites within a logP range of - 9.1 to 5.6. QreSS internal standards confirmed consistent performance (CV < 0.16) and effective recovery (70-130%) of polar to mid-polar metabolites. Quality control dilution series demonstrated that ~ 80% of annotated metabolites could be accurately quantified (Pearson's correlation coefficient > 0.80) within their concentration range. Repeatability was demonstrated through clustering of repeated extractions from a single sample.</p><p><strong>Conclusion: </strong>This LC-MS method is better suited to covering the polar segment of the metabolome than current methods, offering a reliable and efficient approach for accurate quantification of polar metabolites in untargeted metabolomics.</p>","PeriodicalId":18506,"journal":{"name":"Metabolomics","volume":"20 4","pages":"77"},"PeriodicalIF":3.5,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11252196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141627141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MetabolomicsPub Date : 2024-07-16DOI: 10.1007/s11306-024-02148-5
Cara Olivier, Laneke Luies
{"title":"Metabolic insights into HIV/TB co-infection: an untargeted urinary metabolomics approach.","authors":"Cara Olivier, Laneke Luies","doi":"10.1007/s11306-024-02148-5","DOIUrl":"10.1007/s11306-024-02148-5","url":null,"abstract":"<p><strong>Introduction: </strong>Amid the global health crisis, HIV/TB co-infection presents significant challenges, amplifying the burden on patients and healthcare systems alike. Metabolomics offers an innovative window into the metabolic disruptions caused by co-infection, potentially improving diagnosis and treatment monitoring.</p><p><strong>Aim: </strong>This study uses untargeted metabolomics to investigate the urinary metabolic signature of HIV/TB co-infection, enhancing understanding of the metabolic interplay between these infections.</p><p><strong>Methods: </strong>Urine samples from South African adults, categorised into four groups - healthy controls, TB-positive, HIV-positive, and HIV/TB co-infected - were analysed using GCxGC-TOFMS. Metabolites showing significant differences among groups were identified through Kruskal-Wallis and Wilcoxon rank sum tests.</p><p><strong>Results: </strong>Various metabolites (n = 23) were modulated across the spectrum of health and disease states represented in the cohorts. The metabolomic profiles reflect a pronounced disruption in biochemical pathways involved in energy production, amino acid metabolism, gut microbiome, and the immune response, suggesting a bidirectional exacerbation between HIV and TB. While both diseases independently perturb the host's metabolism, their co-infection leads to a unique metabolic phenotype, indicative of an intricate interplay rather than a simple additive effect.</p><p><strong>Conclusion: </strong>Metabolic profiling revealed a unique metabolic landscape shaped by HIV/TB co-infection. The findings highlight the potential of urinary differential metabolites for co-infection, offering a non-invasive tool for enhancing diagnostic precision and tailoring therapeutic interventions. Future research should focus on expanding sample sizes and integrating longitudinal analyses to build upon these foundational insights, paving the way for metabolomic applications in combating these concurrent pandemics.</p>","PeriodicalId":18506,"journal":{"name":"Metabolomics","volume":"20 4","pages":"78"},"PeriodicalIF":3.5,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11252185/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141627140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MetabolomicsPub Date : 2024-07-13DOI: 10.1007/s11306-024-02140-z
Gaohang Mu, Xiangyu Cao, Lianbo Shao, Han Shen, Xingyou Guo, Yamei Gao, Chengkai Su, Hongyou Fan, You Yu, Zhenya Shen
{"title":"Progress and perspectives of metabolic biomarkers in human aortic dissection.","authors":"Gaohang Mu, Xiangyu Cao, Lianbo Shao, Han Shen, Xingyou Guo, Yamei Gao, Chengkai Su, Hongyou Fan, You Yu, Zhenya Shen","doi":"10.1007/s11306-024-02140-z","DOIUrl":"10.1007/s11306-024-02140-z","url":null,"abstract":"<p><strong>Background: </strong>Aortic dissection (AD) significantly threated human cardiovascular health, extensive clinical-scientific research programs have been executed to uncover the pathogenesis and prevention. Unfortunately, no specific biomarker was identified for the causality or development of human AD.</p><p><strong>Aim of review: </strong>Metabolomics, a high-throughput technique capable of quantitatively detecting metabolites, holds considerable promise in discovering specific biomarkers and unraveling the underlying pathways involved. Aiming to provide a metabolite prediction in human AD, we collected the metabolomics data from 2003 to 2023, and diligently scrutinized with the online system MetaboAnalyst 6.0.</p><p><strong>Key scientific concepts of review: </strong>Based on the data obtained, we have concluded the metabolic dynamics were highly correlated with human AD. Such metabolites (choline, serine and uridine) were frequently involved in the AD. Besides, the pathways, including amino acids metabolism and lipids metabolism, were also dysregulated in the disease. Due to the current limitation of metabolism analysis, the integrative omics data including genomics, transcriptomics, and proteomics were required for developing the specific biomarker for AD.</p>","PeriodicalId":18506,"journal":{"name":"Metabolomics","volume":"20 4","pages":"76"},"PeriodicalIF":3.5,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141603874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MetabolomicsPub Date : 2024-07-09DOI: 10.1007/s11306-024-02137-8
Hai-Bo Wang, Xuan Xiao, Wen Dai, Yan Cui, Wan-Man Li, Rui Peng, Liu Hu, Shao-Ting Wang
{"title":"Dispel some mist on circulating biopterins: measurement, physiological interval and pathophysiological implication.","authors":"Hai-Bo Wang, Xuan Xiao, Wen Dai, Yan Cui, Wan-Man Li, Rui Peng, Liu Hu, Shao-Ting Wang","doi":"10.1007/s11306-024-02137-8","DOIUrl":"10.1007/s11306-024-02137-8","url":null,"abstract":"<p><strong>Background and aims: </strong>Biopterins, including tetrahydrobiopterin (BH4), dihydrobiopterin (BH2), and biopterin (B), were crucial enzyme cofactors in vivo. Despite their recognized clinical significance, there remain notable research gaps and controversies surrounding experimental outcomes. This study aims to clarify the biopterins-related issues, including analytical art, physiological intervals, and pathophysiological implications.</p><p><strong>Materials and methods: </strong>A novel LC-MS/MS method was developed to comprehensively profile biopterins in plasma, utilizing chemical derivatization and cold-induced phase separation. Subsequently, apparently healthy individuals were enrolled to investigate the physiological ranges. And the relationships between biopterins and biochemical indicators were analyzed to explore the pathophysiological implications.</p><p><strong>Results: </strong>The developed method was validated as reliable for detecting biopterins across the entire physiological range. Timely anti-oxidation was found to be essential for accurate assessment of biopterins. The observed overall mean ± SDs levels were 3.51 ± 0.94, 1.54 ± 0.48, 2.45 ± 0.84 and 5.05 ± 1.14 ng/mL for BH4, BH2, BH4/BH2 and total biopterins. The status of biopterins showed interesting correlations with age, gender, hyperuricemia and overweight.</p><p><strong>Conclusion: </strong>In conjunction with proper anti-oxidation, the newly developed method enables accurate determination of biopterins status in plasma. The observed physiological intervals and pathophysiological implications provide fundamental yet inspiring support for further clinical researches.</p>","PeriodicalId":18506,"journal":{"name":"Metabolomics","volume":"20 4","pages":"74"},"PeriodicalIF":3.5,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MetabolomicsPub Date : 2024-07-09DOI: 10.1007/s11306-024-02138-7
Moustafa M Zohair, Wang Dongmei, Kuniyoshi Shimizu
{"title":"Metabolic picture of microbial interaction: chemical crosstalk during co-cultivation between three dominant genera of bacteria and fungi in medicinal plants rhizosphere.","authors":"Moustafa M Zohair, Wang Dongmei, Kuniyoshi Shimizu","doi":"10.1007/s11306-024-02138-7","DOIUrl":"10.1007/s11306-024-02138-7","url":null,"abstract":"<p><strong>Introduction: </strong>Microbial communities affect several aspects of the earth's ecosystem through their metabolic interaction. The dynamics of this interaction emerge from complex multilevel networks of crosstalk. Elucidation of this interaction could help us to maintain the balance for a sustainable future.</p><p><strong>Objectives: </strong>To investigate the chemical language among highly abundant microbial genera in the rhizospheres of medicinal plants based on the metabolomic analysis at the interaction level.</p><p><strong>Methods: </strong>Coculturing experiments involving three microbial species: Aspergillus (A), Trichoderma (T), and Bacillus (B), representing fungi (A, T) and bacteria (B), respectively. These experiments encompassed various interaction levels, including dual cultures (AB, AT, TB) and triple cultures (ATB). Metabolic profiling by LC-QTOFMS revealed the effect of interaction level on the productivity and diversity of microbial specialized metabolites.</p><p><strong>Results: </strong>The ATB interaction had the richest profile, while the bacterial profile in the monoculture condition had the lowest. Two native compounds of the Aspergillus genus, aspergillic acid and the dipeptide asperopiperazine B, exhibited decreased levels in the presence of the AT interaction and were undetectable in the presence of bacteria during the interaction. Trichodermarin N and Trichodermatide D isolated from Trichoderma species exclusively detected during coexistence with bacteria (TB and ATB). These findings indicate that the presence of Bacillus activates cryptic biosynthetic gene clusters in Trichoderma. The antibacterial activity of mixed culture extracts was stronger than that of the monoculture extracts. The TB extract exhibited strong antifungal activity compared to the monoculture extract and other mixed culture treatments.</p><p><strong>Conclusion: </strong>The elucidation of medicinal plant microbiome interaction chemistry and its effect on the environment will also be of great interest in the context of medicinal plant health Additionally, it sheds light on the content of bioactive constituents, and facilitating the discovery of novel antimicrobials.</p>","PeriodicalId":18506,"journal":{"name":"Metabolomics","volume":"20 4","pages":"75"},"PeriodicalIF":3.5,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MetabolomicsPub Date : 2024-07-09DOI: 10.1007/s11306-024-02135-w
Jonathan D Mosley, Warwick B Dunn, Julia Kuligowski, Matthew R Lewis, María Eugenia Monge, Candice Ulmer Holland, Dajana Vuckovic, Krista A Zanetti, Tracey B Schock
{"title":"Metabolomics 2023 workshop report: moving toward consensus on best QA/QC practices in LC-MS-based untargeted metabolomics.","authors":"Jonathan D Mosley, Warwick B Dunn, Julia Kuligowski, Matthew R Lewis, María Eugenia Monge, Candice Ulmer Holland, Dajana Vuckovic, Krista A Zanetti, Tracey B Schock","doi":"10.1007/s11306-024-02135-w","DOIUrl":"10.1007/s11306-024-02135-w","url":null,"abstract":"<p><strong>Introduction: </strong>During the Metabolomics 2023 conference, the Metabolomics Quality Assurance and Quality Control Consortium (mQACC) presented a QA/QC workshop for LC-MS-based untargeted metabolomics.</p><p><strong>Objectives: </strong>The Best Practices Working Group disseminated recent findings from community forums and discussed aspects to include in a living guidance document.</p><p><strong>Methods: </strong>Presentations focused on reference materials, data quality review, metabolite identification/annotation and quality assurance.</p><p><strong>Results: </strong>Live polling results and follow-up discussions offered a broad international perspective on QA/QC practices.</p><p><strong>Conclusions: </strong>Community input gathered from this workshop series is being used to shape the living guidance document, a continually evolving QA/QC best practices resource for metabolomics researchers.</p>","PeriodicalId":18506,"journal":{"name":"Metabolomics","volume":"20 4","pages":"73"},"PeriodicalIF":3.5,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11233279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MetabolomicsPub Date : 2024-07-08DOI: 10.1007/s11306-024-02142-x
Hsuan Chou, Lucy Godbeer, Max Allsworth, Billy Boyle, Madeleine L Ball
{"title":"Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform.","authors":"Hsuan Chou, Lucy Godbeer, Max Allsworth, Billy Boyle, Madeleine L Ball","doi":"10.1007/s11306-024-02142-x","DOIUrl":"10.1007/s11306-024-02142-x","url":null,"abstract":"<p><strong>Background: </strong>The multitude of metabolites generated by physiological processes in the body can serve as valuable biomarkers for many clinical purposes. They can provide a window into relevant metabolic pathways for health and disease, as well as be candidate therapeutic targets. A subset of these metabolites generated in the human body are volatile, known as volatile organic compounds (VOCs), which can be detected in exhaled breath. These can diffuse from their point of origin throughout the body into the bloodstream and exchange into the air in the lungs. For this reason, breath VOC analysis has become a focus of biomedical research hoping to translate new useful biomarkers by taking advantage of the non-invasive nature of breath sampling, as well as the rapid rate of collection over short periods of time that can occur. Despite the promise of breath analysis as an additional platform for metabolomic analysis, no VOC breath biomarkers have successfully been implemented into a clinical setting as of the time of this review.</p><p><strong>Aim of review: </strong>This review aims to summarize the progress made to address the major methodological challenges, including standardization, that have historically limited the translation of breath VOC biomarkers into the clinic. We highlight what steps can be taken to improve these issues within new and ongoing breath research to promote the successful development of the VOCs in breath as a robust source of candidate biomarkers. We also highlight key recent papers across select fields, critically reviewing the progress made in the past few years to advance breath research.</p><p><strong>Key scientific concepts of review: </strong>VOCs are a set of metabolites that can be sampled in exhaled breath to act as advantageous biomarkers in a variety of clinical contexts.</p>","PeriodicalId":18506,"journal":{"name":"Metabolomics","volume":"20 4","pages":"72"},"PeriodicalIF":3.5,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11230972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141559115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}